Hepatitis

Key Points

• Hepatitis is inflammation of the liver and is classified as acute (6 months or less) or chronic (more than 6 months).
• Common causes include viral hepatitis (A-E), autoimmune hepatitis, and alcohol- or drug-related hepatic injury.
• Early findings can be nonspecific (fatigue, anorexia, nausea, vomiting); progression can include jaundice, RUQ pain, hepatomegaly, dark urine, and pale stools.
• Severe disease may cause ascites, hepatic encephalopathy, and bleeding risk from impaired hepatic clotting-factor synthesis.
• Nursing priorities include symptom support, serial laboratory monitoring, bleeding precautions, liver-protective teaching, and complication escalation.

Pathophysiology

Hepatitis causes hepatocellular inflammation and injury, reducing the liver’s ability to perform metabolic, synthetic, and detoxification functions. Persistent inflammation can progress to fibrosis, cirrhosis, liver failure, and in some chronic viral forms, increased hepatocellular carcinoma risk.

Classification

Type	Typical route/cause	Chronic potential	Key nursing implications
Hepatitis A	Fecal-oral transmission (food/water contamination)	Usually acute/self-limited	Transmission hygiene, outbreak/travel prevention, vaccine counseling
Hepatitis B	Blood/body fluids, sexual, perinatal	Can become chronic	Monitor long-term complications; vaccine and exposure prevention teaching
Hepatitis C	Blood exposure (needles, transfusion history), less often sexual/perinatal	Frequently chronic	Harm-reduction counseling and antiviral-treatment adherence
Hepatitis D	Requires HBV coinfection/superinfection	Depends on HBV status	Screen/manage with HBV context; higher severity risk
Hepatitis E	Contaminated water	Usually self-limited; may be severe in select patients	Water/sanitation teaching and supportive monitoring
Autoimmune hepatitis	Immune-mediated hepatocyte injury	Often chronic without control	Immunosuppressive therapy monitoring and relapse surveillance
Alcohol/drug-related hepatitis	Chronic alcohol misuse or hepatotoxic drug exposure	Can progress to liver failure	Abstinence support, medication review, and substance-use treatment referral

Nursing Assessment

• Assess symptom pattern:
  • Early: anorexia, nausea, vomiting, fatigue (or asymptomatic presentation)
  • Progressing: jaundice, RUQ pain, hepatomegaly, light-colored stool, dark urine
  • Severe: ascites, altered mental status, bleeding signs
• Monitor hemodynamic/fluid status: vital signs, 24-hour intake/output, daily weight, edema, abdominal girth.
• Assess perfusion and hydration: capillary refill, peripheral pulses, skin turgor, mucous membranes.
• Screen for bleeding risk: hematuria, melena, ecchymosis, gum/IV-site oozing.
• Trend laboratory and diagnostic data:
  • ALT/AST, bilirubin, albumin
  • PT/INR and other coagulation indices
  • Ammonia for encephalopathy risk
  • Viral serologies and cause-specific testing
  • Liver biopsy when etiology or disease extent requires confirmation

Nursing Interventions

• Provide supportive care: rest/activity pacing, hydration support, nutrition optimization with small frequent meals and dietician collaboration.
• Prevent further liver injury:
  • Avoid hepatotoxic medications/substances (for example acetaminophen/paracetamol, alcohol)
  • Reinforce abstinence and substance-use treatment referral when indicated
• Implement bleeding precautions: electric razor, soft oral care, fall/injury minimization, close coagulation trend review.
• Manage symptom burden:
  • Antiemetics and ordered adjuncts to improve intake
  • Itch management with cool showers/baking soda baths and skin-protection measures
  • Emotional support and nonjudgmental counseling
• Monitor progression and escalate early for worsening confusion, severe abdominal distension, uncontrolled bleeding, or signs of liver failure.
• Teach transmission and self-management:
  • Hand hygiene, no sharing personal items, environmental sanitation
  • Risk-reduction for close contacts and vaccination counseling (HAV/HBV where indicated)
  • Follow-up laboratory adherence and return precautions

Pharmacology

Category	Examples	Nursing considerations
Antivirals (chronic viral hepatitis)	Tenofovir, entecavir; DAA regimens for HCV	Monitor adherence, liver labs, adverse effects, and treatment-response labs
Immunosuppressive therapy (autoimmune)	Corticosteroids and steroid-sparing agents	Monitor infection risk, glucose, bone effects, and taper plans
Symptom/supportive medications	Antiemetics, nutritional supplements, selected anxiolytics	Use cautiously in hepatic impairment; monitor sedation and hepatic metabolism burden
Vaccines/immunoprophylaxis	HAV/HBV vaccines; immune globulin for select exposures/contacts	Reinforce timing, risk groups, and post-exposure counseling

Clinical Judgment Application

Clinical Scenario

A client with hepatitis develops increasing abdominal girth, new confusion, elevated PT/INR, and rising ammonia.

• Recognize Cues: Ascites progression, altered cognition, coagulopathy, hyperammonemia.
• Analyze Cues: Worsening hepatic dysfunction with high risk of hepatic encephalopathy and bleeding.
• Prioritize Hypotheses: Immediate safety threats are neurologic decline and hemorrhagic complications.
• Generate Solutions: Escalate to provider, institute bleeding/fall precautions, trend critical labs, and prepare ordered therapies.
• Take Action: Intensify monitoring, enforce precautions, support hemodynamics/nutrition, and reinforce family teaching.
• Evaluate Outcomes: Mental status stabilizes, bleeding signs remain absent, and laboratory trends improve or plateau.

Related Concepts

• hepatitis-b - Virus-specific HBV transmission, serology, and chronic management.
• hepatitis-c - HCV chronicity and DAA-focused cure pathway.
• ascites - Common severe complication of advanced hepatic dysfunction.
• liver-failure - End-stage decompensation and transplant-level escalation.
• substance-use-disorders - Recovery pathways for alcohol/drug-associated hepatitis risk.

Self-Check

1. Which findings suggest progression from early hepatitis to severe hepatic dysfunction?
2. Why are PT/INR and ammonia key trending labs in advanced hepatitis?
3. What client teaching reduces both transmission risk and future liver injury?